<DOC>
	<DOCNO>NCT00004226</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . PURPOSE : Phase I/II trial study effectiveness radiation therapy follow surgery treat patient recurrent second primary cancer head neck follow previous radiation therapy .</brief_summary>
	<brief_title>Radiation Therapy Following Surgery Treating Patients With Recurrent Second Primary Cancer Head Neck Following Previous Radiation Therapy</brief_title>
	<detailed_description>OBJECTIVES : - Determine survival local control previously irradiate patient high risk local failure follow regional resection recurrent second primary head neck cancer . - Determine acute late toxicity treatment patient . - Determine pattern disease failure patient treatment . - Determine change quality life patient treatment . OUTLINE : Patients receive fractionate dos radiotherapy five time weekly 6 week . Quality life assess prior study , 2 month radiotherapy , every 3 month remainder year 1 , every 4 month year 2-3 , every 6 month year 4-5 , annually thereafter . Patients follow 2 month radiotherapy , every 3 month year 1 , every 4 month year 2 , every 6 month year 3-5 , annually thereafter . PROJECTED ACCRUAL : A total 30 patient accrue study within 5 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma mucosa , recurrent ( primary and/or nodal ) , second primary ( positive negative nodal ) , one following : Oral cavity Oropharynx Hypopharynx Larynx Paranasal sinus Neck disease unknown origin No distant metastases No primary nasopharynx Must complete gross resection disease Must positive final margin , soft tissue extension primary , positive extracapsular extension lymph node disease , least 4 positive node without extracapsular extension Reirradiation field must overlap previous field minimum 3 cm height , width , length At least 6 month since prior radiotherapy overlap volume least 45 Gy No grade 3 4 toxicity follow organ tissue : RTOG grade 3 4 skin , subcutaneous tissue , larynx , joint , RTOG grade 4 mucous membrane bone prior radiotherapy Radiotherapy must begin within 612 week surgery Prior radiotherapy record must available PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : At least 3 month Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant No history invasive malignancy would expect cause death within 3 year PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
</DOC>